BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,457,702 | +1680.4% | 69,040 | +945.3% | 0.00% | – |
Q2 2023 | $418,889 | -82.9% | 6,605 | -70.0% | 0.00% | -100.0% |
Q4 2021 | $2,445,000 | +789.1% | 22,008 | +649.8% | 0.00% | – |
Q1 2021 | $275,000 | -71.9% | 2,935 | -68.0% | 0.00% | -100.0% |
Q4 2020 | $980,000 | +219.2% | 9,159 | +188.5% | 0.00% | – |
Q3 2020 | $307,000 | -20.9% | 3,175 | -35.7% | 0.00% | – |
Q2 2020 | $388,000 | +1516.7% | 4,941 | +1166.9% | 0.00% | – |
Q1 2020 | $24,000 | -95.8% | 390 | -94.5% | 0.00% | – |
Q4 2019 | $573,000 | -67.1% | 7,152 | -69.8% | 0.00% | -100.0% |
Q3 2019 | $1,741,000 | -7.7% | 23,691 | +18.5% | 0.00% | 0.0% |
Q2 2019 | $1,887,000 | +36.4% | 19,997 | +15.8% | 0.00% | +100.0% |
Q1 2019 | $1,383,000 | +1297.0% | 17,275 | +841.9% | 0.00% | – |
Q4 2018 | $99,000 | -47.6% | 1,834 | -24.3% | 0.00% | – |
Q3 2018 | $189,000 | +22.7% | 2,422 | -0.4% | 0.00% | – |
Q2 2018 | $154,000 | 0.0% | 2,432 | +44.4% | 0.00% | – |
Q1 2018 | $154,000 | -68.2% | 1,684 | -73.8% | 0.00% | – |
Q4 2017 | $484,000 | +2925.0% | 6,428 | +2719.3% | 0.00% | – |
Q3 2017 | $16,000 | +33.3% | 228 | 0.0% | 0.00% | – |
Q2 2017 | $12,000 | +33.3% | 228 | 0.0% | 0.00% | – |
Q1 2017 | $9,000 | +28.6% | 228 | 0.0% | 0.00% | – |
Q4 2016 | $7,000 | – | 228 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |